{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:50:55Z","timestamp":1793274655168,"version":"4.5.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-024-09012-3","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T06:36:02Z","timestamp":1735886162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Group 3 Innate Lymphoid Cells: A Potential Therapeutic Target for Steroid Resistant Asthma"],"prefix":"10.1007","volume":"68","author":[{"given":"Marzhan","family":"Berkinbayeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peisong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"issue":"10258","key":"9012_CR1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD Diseases","year":"2020","unstructured":"Diseases GBD, Injuries C (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396(10258):1204\u20131222","journal-title":"Lancet"},{"key":"9012_CR2","doi-asserted-by":"crossref","unstructured":"Zhang S et al (2024) Novel perspectives of TSLP and RXR signaling in corticosteroid-resistant asthma: updates on TSLP blockers. Curr Med Chem Online ahead of print","DOI":"10.2174\/0109298673268237231124064413"},{"issue":"3","key":"9012_CR3","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/0091-6749(93)90114-U","volume":"92","author":"D Cypcar","year":"1993","unstructured":"Cypcar D, Busse WW (1993) Steroid-resistant asthma. J Allergy Clin Immunol 92(3):362\u2013372","journal-title":"J Allergy Clin Immunol"},{"issue":"7534","key":"9012_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nature14189","volume":"517","author":"D Artis","year":"2015","unstructured":"Artis D, Spits H (2015) The biology of innate lymphoid cells. Nature 517(7534):293\u2013301","journal-title":"Nature"},{"issue":"5","key":"9012_CR5","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","volume":"174","author":"E Vivier","year":"2018","unstructured":"Vivier E et al (2018) Innate lymphoid cells: 10 years on. Cell 174(5):1054\u20131066","journal-title":"Cell"},{"issue":"3","key":"9012_CR6","doi-asserted-by":"publisher","first-page":"138","DOI":"10.2500\/aap.2019.40.4217","volume":"40","author":"MA Pasha","year":"2019","unstructured":"Pasha MA et al (2019) Role of innate lymphoid cells in allergic diseases. Allergy Asthma Proc 40(3):138\u2013145","journal-title":"Allergy Asthma Proc"},{"key":"9012_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.imlet.2018.03.007","volume":"205","author":"E Ferretti","year":"2019","unstructured":"Ferretti E et al (2019) Canonical and non-canonical adenosinergic pathways. Immunol Lett 205:25\u201330","journal-title":"Immunol Lett"},{"issue":"6","key":"9012_CR8","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41575-024-00906-3","volume":"21","author":"V Horn","year":"2024","unstructured":"Horn V, Sonnenberg GF (2024) Group 3 innate lymphoid cells in intestinal health and disease. Nat Rev Gastroenterol Hepatol 21(6):428\u2013443","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"9012_CR9","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1164\/rccm.201405-0859PP","volume":"190","author":"J Chesne","year":"2014","unstructured":"Chesne J et al (2014) IL-17 in severe asthma. Where do we stand? Am J Respir Crit Care Med 190(10):1094\u20131101","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"9012_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4193\/Rhin18.131","volume":"57","author":"CC Huang","year":"2019","unstructured":"Huang CC et al (2019) Impact of cigarette smoke and IL-17A activation on asthmatic patients with chronic rhinosinusitis. Rhinology 57(1):57\u201366","journal-title":"Rhinology"},{"key":"9012_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1146\/annurev.physiol.010908.163200","volume":"71","author":"Q Hamid","year":"2009","unstructured":"Hamid Q, Tulic M (2009) Immunobiology of asthma. Annu Rev Physiol 71:489\u2013507","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"9012_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12931-016-0462-0","volume":"17","author":"M Wang","year":"2016","unstructured":"Wang M et al (2016) Impaired anti-inflammatory action of glucocorticoid in neutrophil from patients with steroid-resistant asthma. Respir Res 17(1):153","journal-title":"Respir Res"},{"issue":"9","key":"9012_CR13","doi-asserted-by":"publisher","first-page":"E181","DOI":"10.1503\/cmaj.080612","volume":"181","author":"P Subbarao","year":"2009","unstructured":"Subbarao P, Mandhane PJ, Sears MR (2009) Asthma: epidemiology, etiology and risk factors. CMAJ 181(9):E181\u2013E190","journal-title":"CMAJ"},{"key":"9012_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2147\/JAA.S153097","volume":"11","author":"I Esteban-Gorgojo","year":"2018","unstructured":"Esteban-Gorgojo I et al (2018) Non-eosinophilic asthma: current perspectives. J Asthma Allergy 11:267\u2013281","journal-title":"J Asthma Allergy"},{"key":"9012_CR15","first-page":"53","volume":"7","author":"HH Walford","year":"2014","unstructured":"Walford HH, Doherty TA (2014) Diagnosis and management of eosinophilic asthma: a US perspective. J Asthma Allergy 7:53\u201365","journal-title":"J Asthma Allergy"},{"issue":"6","key":"9012_CR16","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.jaci.2015.10.007","volume":"136","author":"DYM Leung","year":"2015","unstructured":"Leung DYM (2015) The Journal of Allergy and Clinical Immunology: a 17-year perspective. J Allergy Clin Immunol 136(6):1471\u20131473 e4","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"9012_CR17","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3390\/ijms20030713","volume":"20","author":"JS Jeong","year":"2019","unstructured":"Jeong JS et al (2019) A novel insight on endotyping heterogeneous severe asthma based on endoplasmic reticulum stress: beyond the \"type 2\/non-type 2 dichotomy\". Int J Mol Sci 20(3):713","journal-title":"Int J Mol Sci"},{"issue":"7","key":"9012_CR18","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1136\/thorax.57.7.643","volume":"57","author":"J Douwes","year":"2002","unstructured":"Douwes J et al (2002) Non-eosinophilic asthma: importance and possible mechanisms. Thorax 57(7):643\u2013648","journal-title":"Thorax"},{"key":"9012_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2466-13-11","volume":"13","author":"FN Schleich","year":"2013","unstructured":"Schleich FN et al (2013) Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation. BMC Pulm Med 13:11","journal-title":"BMC Pulm Med"},{"issue":"2","key":"9012_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11882-008-0028-4","volume":"8","author":"IM Adcock","year":"2008","unstructured":"Adcock IM et al (2008) Steroid resistance in asthma: mechanisms and treatment options. Curr Allergy Asthma Rep 8(2):171\u2013178","journal-title":"Curr Allergy Asthma Rep"},{"issue":"11","key":"9012_CR21","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1111\/all.13184","volume":"72","author":"P Ntontsi","year":"2017","unstructured":"Ntontsi P et al (2017) Clinical, functional and inflammatory characteristics in patients with paucigranulocytic stable asthma: comparison with different sputum phenotypes. Allergy 72(11):1761\u20131767","journal-title":"Allergy"},{"issue":"3","key":"9012_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1164\/rccm.201609-1830OC","volume":"196","author":"RY Kim","year":"2017","unstructured":"Kim RY et al (2017) Role for NLRP3 inflammasome-mediated, IL-1beta-dependent responses in severe, steroid-resistant asthma. Am J Respir Crit Care Med 196(3):283\u2013297","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"9012_CR23","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1164\/rccm.200304-503OC","volume":"168","author":"R Chaudhuri","year":"2003","unstructured":"Chaudhuri R et al (2003) Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 168(11):1308\u20131311","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"9012_CR24","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1164\/rccm.200511-1746OC","volume":"175","author":"SC Lazarus","year":"2007","unstructured":"Lazarus SC et al (2007) Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 175(8):783\u2013790","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"9012_CR25","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.2165\/00003495-200565110-00005","volume":"65","author":"E Livingston","year":"2005","unstructured":"Livingston E, Thomson NC, Chalmers GW (2005) Impact of smoking on asthma therapy: a critical review of clinical evidence. Drugs 65(11):1521\u20131536","journal-title":"Drugs"},{"issue":"3","key":"9012_CR26","doi-asserted-by":"publisher","first-page":"851","DOI":"10.4049\/jimmunol.1700933","volume":"201","author":"MF Serra","year":"2018","unstructured":"Serra MF et al (2018) Repeated allergen exposure in A\/J mice causes steroid-insensitive asthma via a defect in glucocorticoid receptor bioavailability. J Immunol 201(3):851\u2013860","journal-title":"J Immunol"},{"issue":"1","key":"9012_CR27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1182\/blood.V79.1.213.213","volume":"79","author":"PA Moalli","year":"1992","unstructured":"Moalli PA et al (1992) A mechanism of resistance to glucocorticoids in multiple myeloma: transient expression of a truncated glucocorticoid receptor mRNA. Blood 79(1):213\u2013222","journal-title":"Blood"},{"issue":"1","key":"9012_CR28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1055\/s-0029-1211204","volume":"101","author":"M Karl","year":"1993","unstructured":"Karl M, Chrousos GP (1993) Familial glucocorticoid resistance: an overview. Exp Clin Endocrinol 101(1):30\u201335","journal-title":"Exp Clin Endocrinol"},{"key":"9012_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-94-017-9487-9_2","volume":"841","author":"Y Zhang","year":"2014","unstructured":"Zhang Y et al (2014) TH1\/TH2 cell differentiation and molecular signals. Adv Exp Med Biol 841:15\u201344","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"9012_CR30","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1172\/JCI80911","volume":"125","author":"M Raundhal","year":"2015","unstructured":"Raundhal M et al (2015) High IFN-gamma and low SLPI mark severe asthma in mice and humans. J Clin Invest 125(8):3037\u20133050","journal-title":"J Clin Invest"},{"issue":"7","key":"9012_CR31","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1164\/rccm.200809-1512OC","volume":"179","author":"SE Wenzel","year":"2009","unstructured":"Wenzel SE et al (2009) A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. Am J Respir Crit Care Med 179(7):549\u2013558","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"9012_CR32","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jaci.2015.01.026","volume":"136","author":"ES Chambers","year":"2015","unstructured":"Chambers ES et al (2015) Distinct endotypes of steroid-resistant asthma characterized by IL-17A(high) and IFN-gamma(high) immunophenotypes: potential benefits of calcitriol. J Allergy Clin Immunol 136(3):628\u2013637 e4","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"9012_CR33","doi-asserted-by":"publisher","first-page":"e816","DOI":"10.1002\/iid3.816","volume":"11","author":"S Chu","year":"2023","unstructured":"Chu S et al (2023) NCR negative group 3 innate lymphoid cell (NCR(-) ILC3) participates in abnormal pathology of lung in cigarette smoking-induced COPD mice. Immun Inflamm Dis 11(3):e816","journal-title":"Immun Inflamm Dis"},{"issue":"1","key":"9012_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1365-2222.2008.03151.x","volume":"39","author":"J Tanaka","year":"2009","unstructured":"Tanaka J et al (2009) Human TSLP and TLR3 ligands promote differentiation of Th17 cells with a central memory phenotype under Th2-polarizing conditions. Clin Exp Allergy 39(1):89\u2013100","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"9012_CR35","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.cytogfr.2014.04.005","volume":"25","author":"C Lim","year":"2014","unstructured":"Lim C, Savan R (2014) The role of the IL-22\/IL-22R1 axis in cancer. Cytokine Growth Factor Rev 25(3):257\u2013271","journal-title":"Cytokine Growth Factor Rev"},{"issue":"8","key":"9012_CR36","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1134\/S0006297920080027","volume":"85","author":"IP Shilovskiy","year":"2020","unstructured":"Shilovskiy IP et al (2020) Modern view of neutrophilic asthma molecular mechanisms and therapy. Biochemistry (Mosc) 85(8):854\u2013868","journal-title":"Biochemistry (Mosc)"},{"issue":"5","key":"9012_CR37","first-page":"1092","volume":"159","author":"KE Nograles","year":"2008","unstructured":"Nograles KE et al (2008) Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol 159(5):1092\u20131102","journal-title":"Br J Dermatol"},{"issue":"2","key":"9012_CR38","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.semarthrit.2013.04.006","volume":"43","author":"WB van den Berg","year":"2013","unstructured":"van den Berg WB, McInnes IB (2013) Th17 cells and IL-17 a--focus on immunopathogenesis and immunotherapeutics. Semin Arthritis Rheum 43(2):158\u2013170","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"9012_CR39","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jaci.2013.03.037","volume":"132","author":"AM Nanzer","year":"2013","unstructured":"Nanzer AM et al (2013) Enhanced production of IL-17A in patients with severe asthma is inhibited by 1alpha,25-dihydroxyvitamin D3 in a glucocorticoid-independent fashion. J Allergy Clin Immunol 132(2):297\u2013304 e3","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"9012_CR40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jaci.2016.02.031","volume":"139","author":"Z Zhang","year":"2017","unstructured":"Zhang Z et al (2017) beta-Glucan exacerbates allergic asthma independent of fungal sensitization and promotes steroid-resistant T(H)2\/T(H)17 responses. J Allergy Clin Immunol 139(1):54\u201365 e8","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"9012_CR41","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1165\/rcmb.2012-0423OC","volume":"48","author":"RA Martin","year":"2013","unstructured":"Martin RA et al (2013) Interleukin-1 receptor and caspase-1 are required for the Th17 response in nitrogen dioxide-promoted allergic airway disease. Am J Respir Cell Mol Biol 48(5):655\u2013664","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"10","key":"9012_CR42","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.3390\/jcm8101615","volume":"8","author":"E Theofani","year":"2019","unstructured":"Theofani E et al (2019) Targeting NLRP3 inflammasome activation in severe asthma. J Clin Med 8(10):1615","journal-title":"J Clin Med"},{"issue":"3","key":"9012_CR43","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1378\/chest.14-2337","volume":"148","author":"JJ Fu","year":"2015","unstructured":"Fu JJ et al (2015) Airway IL-1beta and systemic inflammation as predictors of future exacerbation risk in asthma and COPD. Chest 148(3):618\u2013629","journal-title":"Chest"},{"key":"9012_CR44","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.3389\/fimmu.2019.01545","volume":"10","author":"S Timmermans","year":"2019","unstructured":"Timmermans S, Souffriau J, Libert C (2019) A general introduction to glucocorticoid biology. Front Immunol 10:1545","journal-title":"Front Immunol"},{"issue":"1","key":"9012_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.tibs.2023.10.008","volume":"49","author":"R Rodell","year":"2024","unstructured":"Rodell R, Robalin N, Martinez NM (2024) Why U matters: detection and functions of pseudouridine modifications in mRNAs. Trends Biochem Sci 49(1):12\u201327","journal-title":"Trends Biochem Sci"},{"issue":"6","key":"9012_CR46","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.jaci.2004.03.018","volume":"113","author":"JG Matthews","year":"2004","unstructured":"Matthews JG et al (2004) Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. J Allergy Clin Immunol 113(6):1100\u20131108","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"9012_CR47","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12931-023-02395-5","volume":"24","author":"LX He","year":"2023","unstructured":"He LX et al (2023) Group 3 innate lymphoid cells secret neutrophil chemoattractants and are insensitive to glucocorticoid via aberrant GR phosphorylation. Respir Res 24(1):90","journal-title":"Respir Res"},{"issue":"4","key":"9012_CR48","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.tem.2018.01.010","volume":"29","author":"T Kino","year":"2018","unstructured":"Kino T (2018) GR-regulating serine\/threonine kinases: new physiologic and pathologic implications. Trends Endocrinol Metab 29(4):260\u2013270","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"9012_CR49","first-page":"598","volume":"250","author":"RP Schleimer","year":"1989","unstructured":"Schleimer RP et al (1989) An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils. J Pharmacol Exp Ther 250(2):598\u2013605","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"9012_CR50","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1165\/rcmb.2017-0356OC","volume":"59","author":"J Klockgether","year":"2018","unstructured":"Klockgether J et al (2018) Long-term microevolution of Pseudomonas aeruginosa differs between mildly and severely affected cystic fibrosis lungs. Am J Respir Cell Mol Biol 59(2):246\u2013256","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"13","key":"9012_CR51","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1056\/NEJMoa0911353","volume":"365","author":"KG Tantisira","year":"2011","unstructured":"Tantisira KG et al (2011) Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. N Engl J Med 365(13):1173\u20131183","journal-title":"N Engl J Med"},{"issue":"1","key":"9012_CR52","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.it.2015.11.003","volume":"37","author":"CH Kim","year":"2016","unstructured":"Kim CH, Hashimoto-Hill S, Kim M (2016) Migration and tissue tropism of innate lymphoid cells. Trends Immunol 37(1):68\u201379","journal-title":"Trends Immunol"},{"issue":"3","key":"9012_CR53","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jaci.2014.11.001","volume":"135","author":"F Annunziato","year":"2015","unstructured":"Annunziato F, Romagnani C, Romagnani S (2015) The 3 major types of innate and adaptive cell-mediated effector immunity. J Allergy Clin Immunol 135(3):626\u2013635","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"9012_CR54","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/eji.202048696","volume":"51","author":"L Krabbendam","year":"2021","unstructured":"Krabbendam L et al (2021) Identification of human cytotoxic ILC3s. Eur J Immunol 51(4):811\u2013823","journal-title":"Eur J Immunol"},{"issue":"1","key":"9012_CR55","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/intimm\/dxv052","volume":"28","author":"SA van de Pavert","year":"2016","unstructured":"van de Pavert SA, Vivier E (2016) Differentiation and function of group 3 innate lymphoid cells, from embryo to adult. Int Immunol 28(1):35\u201342","journal-title":"Int Immunol"},{"issue":"6371","key":"9012_CR56","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1126\/science.aam5809","volume":"359","author":"Y Huang","year":"2018","unstructured":"Huang Y et al (2018) S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense. Science 359(6371):114\u2013119","journal-title":"Science"},{"issue":"10","key":"9012_CR57","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/s41590-021-01024-x","volume":"22","author":"R Fiancette","year":"2021","unstructured":"Fiancette R et al (2021) Reciprocal transcription factor networks govern tissue-resident ILC3 subset function and identity. Nat Immunol 22(10):1245\u20131255","journal-title":"Nat Immunol"},{"issue":"7","key":"9012_CR58","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1111\/all.14196","volume":"75","author":"S Toki","year":"2020","unstructured":"Toki S et al (2020) TSLP and IL-33 reciprocally promote each other's lung protein expression and ILC2 receptor expression to enhance innate type-2 airway inflammation. Allergy 75(7):1606\u20131617","journal-title":"Allergy"},{"key":"9012_CR59","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fimmu.2019.00405","volume":"10","author":"N Jacquelot","year":"2019","unstructured":"Jacquelot N, Luong K, Seillet C (2019) Physiological regulation of innate lymphoid cells. Front Immunol 10:405","journal-title":"Front Immunol"},{"issue":"8","key":"9012_CR60","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1038\/s41590-024-01885-y","volume":"25","author":"N Jaeger","year":"2024","unstructured":"Jaeger N et al (2024) Diversity of group 1 innate lymphoid cells in human tissues. Nat Immunol 25(8):1460\u20131473","journal-title":"Nat Immunol"},{"issue":"19","key":"9012_CR61","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1016\/j.cell.2021.07.029","volume":"184","author":"J Goc","year":"2021","unstructured":"Goc J et al (2021) Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer. Cell 184(19):5015\u20135030 e16","journal-title":"Cell"},{"issue":"8","key":"9012_CR62","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/s41590-019-0425-y","volume":"20","author":"M Cella","year":"2019","unstructured":"Cella M et al (2019) Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues. Nat Immunol 20(8):980\u2013991","journal-title":"Nat Immunol"},{"issue":"1","key":"9012_CR63","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/imr.12712","volume":"286","author":"C Stehle","year":"2018","unstructured":"Stehle C, Hernandez DC, Romagnani C (2018) Innate lymphoid cells in lung infection and immunity. Immunol Rev 286(1):102\u2013119","journal-title":"Immunol Rev"},{"issue":"6583","key":"9012_CR64","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1126\/science.aaz8777","volume":"375","author":"N Serafini","year":"2022","unstructured":"Serafini N et al (2022) Trained ILC3 responses promote intestinal defense. Science 375(6583):859\u2013863","journal-title":"Science"},{"key":"9012_CR65","doi-asserted-by":"publisher","first-page":"109251","DOI":"10.1016\/j.intimp.2022.109251","volume":"112","author":"X Xie","year":"2022","unstructured":"Xie X et al (2022) Luteolin alleviates ulcerative colitis by restoring the balance of NCR(-)ILC3\/NCR(+)ILC3 to repairing impaired intestinal barrier. Int Immunopharmacol 112:109251","journal-title":"Int Immunopharmacol"},{"key":"9012_CR66","doi-asserted-by":"publisher","first-page":"586471","DOI":"10.3389\/fcimb.2021.586471","volume":"11","author":"D Yang","year":"2021","unstructured":"Yang D et al (2021) The role of group 3 innate lymphoid cells in lung infection and immunity. Front Cell Infect Microbiol 11:586471","journal-title":"Front Cell Infect Microbiol"},{"key":"9012_CR67","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3389\/fimmu.2017.01298","volume":"8","author":"DR Withers","year":"2017","unstructured":"Withers DR, Hepworth MR (2017) Group 3 innate lymphoid cells: communications hubs of the intestinal immune system. Front Immunol 8:1298","journal-title":"Front Immunol"},{"key":"9012_CR68","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fimmu.2019.00092","volume":"10","author":"A Ardain","year":"2019","unstructured":"Ardain A et al (2019) Type 3 ILCs in lung disease. Front Immunol 10:92","journal-title":"Front Immunol"},{"issue":"4","key":"9012_CR69","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41419-019-1540-2","volume":"10","author":"B Zeng","year":"2019","unstructured":"Zeng B et al (2019) ILC3 function as a double-edged sword in inflammatory bowel diseases. Cell Death Dis 10(4):315","journal-title":"Cell Death Dis"},{"issue":"4","key":"9012_CR70","doi-asserted-by":"publisher","first-page":"e13156","DOI":"10.1111\/sji.13156","volume":"95","author":"A Marchalot","year":"2022","unstructured":"Marchalot A, Mjosberg J (2022) Innate lymphoid cells in colorectal cancer. Scand J Immunol 95(4):e13156","journal-title":"Scand J Immunol"},{"issue":"1","key":"9012_CR71","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13075-019-1984-x","volume":"21","author":"A Takaki-Kuwahara","year":"2019","unstructured":"Takaki-Kuwahara A et al (2019) CCR6+ group 3 innate lymphoid cells accumulate in inflamed joints in rheumatoid arthritis and produce Th17 cytokines. Arthritis Res Ther 21(1):198","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"9012_CR72","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nrrheum.2016.218","volume":"13","author":"MM Shikhagaie","year":"2017","unstructured":"Shikhagaie MM et al (2017) Innate lymphoid cells in autoimmunity: emerging regulators in rheumatic diseases. Nat Rev Rheumatol 13(3):164\u2013173","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"9012_CR73","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/cea.12353","volume":"44","author":"J Mjosberg","year":"2014","unstructured":"Mjosberg J, Eidsmo L (2014) Update on innate lymphoid cells in atopic and non-atopic inflammation in the airways and skin. Clin Exp Allergy 44(8):1033\u20131043","journal-title":"Clin Exp Allergy"},{"key":"9012_CR74","doi-asserted-by":"publisher","first-page":"1191782","DOI":"10.3389\/fimmu.2023.1191782","volume":"14","author":"V Navarro-Compan","year":"2023","unstructured":"Navarro-Compan V et al (2023) The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases. Front Immunol 14:1191782","journal-title":"Front Immunol"},{"issue":"5","key":"9012_CR75","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.4049\/jimmunol.1501491","volume":"196","author":"F Roan","year":"2016","unstructured":"Roan F et al (2016) CD4+ Group 1 Innate Lymphoid Cells (ILC) form a functionally distinct ILC subset that is increased in systemic sclerosis. J Immunol 196(5):2051\u20132062","journal-title":"J Immunol"},{"issue":"7","key":"9012_CR76","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1177\/1352458516662726","volume":"23","author":"CC Gross","year":"2017","unstructured":"Gross CC et al (2017) Distinct pattern of lesion distribution in multiple sclerosis is associated with different circulating T-helper and helper-like innate lymphoid cell subsets. Mult Scler 23(7):1025\u20131030","journal-title":"Mult Scler"},{"issue":"8","key":"9012_CR77","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1177\/1352458515609795","volume":"22","author":"M Degn","year":"2016","unstructured":"Degn M et al (2016) Increased prevalence of lymphoid tissue inducer cells in the cerebrospinal fluid of patients with early multiple sclerosis. Mult Scler 22(8):1013\u20131020","journal-title":"Mult Scler"},{"issue":"1","key":"9012_CR78","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.alit.2023.06.004","volume":"73","author":"QL Quoc","year":"2024","unstructured":"Quoc QL et al (2024) Contribution of monocyte and macrophage extracellular traps to neutrophilic airway inflammation in severe asthma. Allergol Int 73(1):81\u201393","journal-title":"Allergol Int"},{"key":"9012_CR79","doi-asserted-by":"publisher","first-page":"849155","DOI":"10.3389\/fimmu.2022.849155","volume":"13","author":"AC Jonckheere","year":"2022","unstructured":"Jonckheere AC et al (2022) Innate lymphoid cells are required to induce airway hyperreactivity in a murine neutrophilic asthma model. Front Immunol 13:849155","journal-title":"Front Immunol"},{"issue":"2","key":"9012_CR80","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.immuni.2019.01.012","volume":"50","author":"NA Yudanin","year":"2019","unstructured":"Yudanin NA et al (2019) Spatial and temporal mapping of human innate lymphoid cells reveals elements of tissue specificity. Immunity 50(2):505\u2013519 e4","journal-title":"Immunity"},{"issue":"8","key":"9012_CR81","doi-asserted-by":"publisher","first-page":"110051","DOI":"10.1016\/j.celrep.2021.110051","volume":"37","author":"F Teng","year":"2021","unstructured":"Teng F et al (2021) ILC3s control airway inflammation by limiting T cell responses to allergens and microbes. Cell Rep 37(8):110051","journal-title":"Cell Rep"},{"key":"9012_CR82","doi-asserted-by":"publisher","first-page":"1628620","DOI":"10.1155\/2018\/1628620","volume":"2018","author":"Y Wu","year":"2018","unstructured":"Wu Y et al (2018) Obesity may provide pro-ILC3 development inflammatory environment in asthmatic children. J Immunol Res 2018:1628620","journal-title":"J Immunol Res"},{"issue":"9","key":"9012_CR83","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1111\/all.15378","volume":"77","author":"Z Celebi Sozener","year":"2022","unstructured":"Celebi Sozener Z et al (2022) Innate lymphoid cell subsets in obese asthma patients: difference in activated cells in peripheral blood and their relationship to disease severity. Allergy 77(9):2835\u20132839","journal-title":"Allergy"},{"issue":"1","key":"9012_CR84","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1038\/s41467-022-31491-1","volume":"13","author":"J Ham","year":"2022","unstructured":"Ham J et al (2022) Cigarette smoke aggravates asthma by inducing memory-like type 3 innate lymphoid cells. Nat Commun 13(1):3852","journal-title":"Nat Commun"},{"issue":"1","key":"9012_CR85","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jaci.2017.07.046","volume":"142","author":"ZI Komlosi","year":"2018","unstructured":"Komlosi ZI et al (2018) Human CD40 ligand-expressing type 3 innate lymphoid cells induce IL-10-producing immature transitional regulatory B cells. J Allergy Clin Immunol 142(1):178\u2013194 e11","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"9012_CR86","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nm.3423","volume":"20","author":"HY Kim","year":"2014","unstructured":"Kim HY et al (2014) Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med 20(1):54\u201361","journal-title":"Nat Med"},{"key":"9012_CR87","doi-asserted-by":"crossref","unstructured":"Yang D et al (2023) IL-1beta promotes IL-17A production of ILC3s to aggravate neutrophilic airway inflammation in mice. Immunology Online ahead of print","DOI":"10.1111\/imm.13644"},{"issue":"1","key":"9012_CR88","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12931-021-01799-5","volume":"22","author":"KJ Warren","year":"2021","unstructured":"Warren KJ et al (2021) Neutralization of IL-33 modifies the type 2 and type 3 inflammatory signature of viral induced asthma exacerbation. Respir Res 22(1):206","journal-title":"Respir Res"},{"issue":"4","key":"9012_CR89","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.4049\/jimmunol.1800484","volume":"201","author":"S Seshadri","year":"2018","unstructured":"Seshadri S, Pope RL, Zenewicz LA (2018) Glucocorticoids inhibit group 3 innate lymphocyte IL-22 production. J Immunol 201(4):1267\u20131274","journal-title":"J Immunol"},{"issue":"2","key":"9012_CR90","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/mi.2014.71","volume":"8","author":"DS Allan","year":"2015","unstructured":"Allan DS et al (2015) An in vitro model of innate lymphoid cell function and differentiation. Mucosal Immunol 8(2):340\u2013351","journal-title":"Mucosal Immunol"},{"issue":"18","key":"9012_CR91","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1056\/NEJMoa2030880","volume":"385","author":"CE Brightling","year":"2021","unstructured":"Brightling CE et al (2021) Risankizumab in severe asthma - a phase 2a, placebo-controlled trial. N Engl J Med 385(18):1669\u20131679","journal-title":"N Engl J Med"},{"issue":"5","key":"9012_CR92","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1684\/ejd.2012.1816","volume":"22","author":"T Torres","year":"2012","unstructured":"Torres T et al (2012) Etanercept-induced asthma in a psoriatic patient resolving with transition to ustekinumab. Eur J Dermatol 22(5):696\u2013697","journal-title":"Eur J Dermatol"},{"key":"9012_CR93","unstructured":"Safety, tolerability, and efficacy of AIN457 in patients with uncontrolled asthma. Available at: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01478360."},{"key":"9012_CR94","unstructured":"Study to assess the efficacy and safety of CJM112 in patients with inadequately controlled severe asthma. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03299686."},{"issue":"1","key":"9012_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2049-6958-10-1","volume":"10","author":"F Menzella","year":"2015","unstructured":"Menzella F et al (2015) Tailored therapy for severe asthma. Multidiscip Respir Med 10(1):1","journal-title":"Multidiscip Respir Med"},{"issue":"4","key":"9012_CR96","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrd1342","volume":"3","author":"M Braddock","year":"2004","unstructured":"Braddock M, Quinn A (2004) Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention. Nat Rev Drug Discov 3(4):330\u2013339","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"9012_CR97","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jaci.2021.04.010","volume":"149","author":"YE Badi","year":"2022","unstructured":"Badi YE et al (2022) Mapping atopic dermatitis and anti-IL-22 response signatures to type 2-low severe neutrophilic asthma. J Allergy Clin Immunol 149(1):89\u2013101","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"9012_CR98","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12931-021-01743-7","volume":"22","author":"D Lamb","year":"2021","unstructured":"Lamb D et al (2021) RORgammat inhibitors block both IL-17 and IL-22 conferring a potential advantage over anti-IL-17 alone to treat severe asthma. Respir Res 22(1):158","journal-title":"Respir Res"},{"issue":"19","key":"9012_CR99","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1056\/NEJMoa2034975","volume":"384","author":"A Menzies-Gow","year":"2021","unstructured":"Menzies-Gow A et al (2021) Tezepelumab in adults and adolescents with severe, uncontrolled asthma. N Engl J Med 384(19):1800\u20131809","journal-title":"N Engl J Med"},{"issue":"7","key":"9012_CR100","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1164\/rccm.200601-072OC","volume":"174","author":"EM Erin","year":"2006","unstructured":"Erin EM et al (2006) The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma. Am J Respir Crit Care Med 174(7):753\u2013762","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"9012_CR101","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1056\/NEJMoa050580","volume":"354","author":"MA Berry","year":"2006","unstructured":"Berry MA et al (2006) Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med 354(7):697\u2013708","journal-title":"N Engl J Med"},{"issue":"12","key":"9012_CR102","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1136\/thx.2005.045260","volume":"60","author":"PH Howarth","year":"2005","unstructured":"Howarth PH et al (2005) Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax 60(12):1012\u20131018","journal-title":"Thorax"},{"issue":"1","key":"9012_CR103","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.alit.2021.07.004","volume":"71","author":"S Chen","year":"2022","unstructured":"Chen S et al (2022) Prevention of IL-6 signaling ameliorates toluene diisocyanate-induced steroid-resistant asthma. Allergol Int 71(1):73\u201382","journal-title":"Allergol Int"},{"issue":"2","key":"9012_CR104","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.jaci.2014.07.039","volume":"135","author":"ML Hernandez","year":"2015","unstructured":"Hernandez ML et al (2015) IL-1 receptor antagonist reduces endotoxin-induced airway inflammation in healthy volunteers. J Allergy Clin Immunol 135(2):379\u2013385","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"9012_CR105","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1164\/rccm.201212-2318OC","volume":"188","author":"WW Busse","year":"2013","unstructured":"Busse WW et al (2013) Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma. Am J Respir Crit Care Med 188(11):1294\u20131302","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"9012_CR106","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/j.1398-9995.2009.02122.x","volume":"64","author":"M Humbert","year":"2009","unstructured":"Humbert M et al (2009) Masitinib, a c-kit\/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics. Allergy 64(8):1194\u20131201","journal-title":"Allergy"},{"key":"9012_CR107","doi-asserted-by":"publisher","first-page":"983852","DOI":"10.3389\/fimmu.2022.983852","volume":"13","author":"G Kardas","year":"2022","unstructured":"Kardas G et al (2022) Monoclonal antibodies in the management of asthma: dead ends, current status and future perspectives. Front Immunol 13:983852","journal-title":"Front Immunol"},{"issue":"1","key":"9012_CR108","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1183\/09031936.00123612","volume":"41","author":"A Kirsten","year":"2013","unstructured":"Kirsten A et al (2013) The anti-IL-17A antibody secukinumab does not attenuate ozone-induced airway neutrophilia in healthy volunteers. Eur Respir J 41(1):239\u2013241","journal-title":"Eur Respir J"},{"issue":"9","key":"9012_CR109","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.3390\/biomedicines10092330","volume":"10","author":"L Calzetta","year":"2022","unstructured":"Calzetta L et al (2022) Investigational treatments in Phase I and II clinical trials: a systematic review in asthma. Biomedicines 10(9):2330","journal-title":"Biomedicines"},{"key":"9012_CR110","doi-asserted-by":"publisher","first-page":"1005517","DOI":"10.3389\/fimmu.2022.1005517","volume":"13","author":"J Ham","year":"2022","unstructured":"Ham J et al (2022) Memory-like innate lymphoid cells in the pathogenesis of asthma. Front Immunol 13:1005517","journal-title":"Front Immunol"},{"issue":"5","key":"9012_CR111","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/acr2.11135","volume":"2","author":"LA Monteagudo","year":"2020","unstructured":"Monteagudo LA, Boothby A, Gertner E (2020) Continuous intravenous anakinra infusion to calm the cytokine storm in macrophage activation syndrome. ACR Open Rheumatol 2(5):276\u2013282","journal-title":"ACR Open Rheumatol"},{"issue":"21","key":"9012_CR112","doi-asserted-by":"publisher","first-page":"e129055","DOI":"10.1172\/jci.insight.129055","volume":"4","author":"MS Godwin","year":"2019","unstructured":"Godwin MS et al (2019) IL-1RA regulates immunopathogenesis during fungal-associated allergic airway inflammation. JCI Insight 4(21):e129055","journal-title":"JCI Insight"},{"issue":"1","key":"9012_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1744666X.2023.2125380","volume":"19","author":"AY Wu","year":"2023","unstructured":"Wu AY, Peebles RS (2023) The emerging role of IL-23 in asthma and its clinical implications. Expert Rev Clin Immunol 19(1):1\u20135","journal-title":"Expert Rev Clin Immunol"},{"issue":"9664","key":"9012_CR114","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0140-6736(09)60140-9","volume":"373","author":"A Gottlieb","year":"2009","unstructured":"Gottlieb A et al (2009) Ustekinumab, a human interleukin 12\/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial. Lancet 373(9664):633\u2013640","journal-title":"Lancet"},{"issue":"1","key":"9012_CR115","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3109\/09546634.2013.782095","volume":"25","author":"A Amarnani","year":"2014","unstructured":"Amarnani A et al (2014) Concurrent treatment of chronic psoriasis and asthma with ustekinumab. J Dermatolog Treat 25(1):63\u201366","journal-title":"J Dermatolog Treat"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-024-09012-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-024-09012-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-024-09012-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T08:08:16Z","timestamp":1735891696000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-024-09012-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":115,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9012"],"URL":"https:\/\/doi.org\/10.1007\/s12016-024-09012-3","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,27]]},"assertion":[{"value":"13 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}